localized sclerodermamorpheatreatmentMorphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000. Morphea occurs most frequently in children aged 2–14 years, and the disease exhibits a ...
scleroderma start with en coup de sabre and progress to have soft tissue involvement in the upper face. Patients can have seizures, headaches, visual changes, and atrophy of thesalivary glandsand hemiatrophy of thetongueon the same side as the facial atrophy. Any reparative surgical treatment ...
英文: Nodules on localized scleroderma or morphea (Fren)中文: 局限型硬皮病的结节(法语) 英文: Superficial morphea in a man中文: 浅表性局限性硬皮病男性患者例 英文: Disabling Pansclerotic morphea of children中文: 儿童致残性全硬化性限界性硬皮病 ...
Successful Treatment of Pansclerotic Morphea with Imatinib Mesylate in a Pediatric Patient 来自 ResearchGate 喜欢 0 阅读量: 11 作者:T Banks,V Steen,I Katona,O Jones 摘要: Juvenile localized scleroderma (JLS) is a childhood condition consisting of a number of subtypes, the most severe of which...
Localized scleroderma (LoS) is a聽very heterogeneous connective tissue disease characterized by progressive sclerosis of the skin with possible involvement of extracutaneous structures. Both children and adults can be affected but show different frequencies for the individual subtypes of the disease. The ...
Morphea in adults and children cohort II: Patients with morphea experience delay in diagnosis and large variation in treatment Little is known about the diagnosis, evaluation, and therapy of morphea (localized scleroderma) in the United States. Delays in diagnosis and initiation of... W Johnson...
Morphea, also known as localized scleroderma is a chronic disease of unknown etiology, characterized by fibrous deposition and obliteration of vessels in the skin. This disease has a wide clinical spectrum, ranging from mild hyperpigmented plaques to severe, invalidating generalized and pansclerotic fo...
Linear morphea is the most common form of localized scleroderma in children. The pathogenesis of this disorder is unknown. We report a child with a 6-year ... M Mhrenschlager,C Jung,J Ring,... - 《Pediatric Dermatology》 被引量: 47发表: 1999年 Efficacy of bosentan in treatment of unr...
Treatment of Generalized Deep Morphea With Everolimuslocalized sclerodermaThis case report describes the treatment of generalized deep morphea with everolimus.doi:10.1001/jamadermatol.2016.2338RybojadStMichelStRouxStJenniferStBouazizStJean-DavidStFrumholtz...
in addition, several case reports have documented successful treatment of systemic scleroderma with infliximab. for our patient, tnfsection editor: erik j. stratman, mdassistant section editors: william d. aughenbaugh, mdmichael p. heffernan, md...